ORBIMED ADVISORS LLC

Average Profitability
0.2%
Insider Buys Quantity
102
Insider Buys Sum
$601.79M
Insider Sells Quantity
209
Insider Sells Sum
$1.41B

Insider Activity of ORBIMED ADVISORS LLC

According to the SEC Form 4 filings, ORBIMED ADVISORS LLC, being in a position of

  1. director at ARS Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 952377 shares for $12.59M,
    over all time since 2023-08-29, has bought 500000 shares for $3.1M, and sold 952377 shares for $12.59M.

The largest purchase of all time was on 2020-09-25 and amounted to 2473600 shares of Prelude Therapeutics Incorporated for $47M.

The largest sale of all time was on 2021-03-01 and amounted to 1220000 shares of SpringWorks Therapeutics, Inc. for $101.49M.

Biography of ORBIMED ADVISORS LLC

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $5,000,02425
Sells
 $75,314,4624295

Comparison of Insiders on Amount of Buys and Sells

2025-03-12SaleDisc Medicine, Inc.
IRON
director
83,182
0.243%
$54.45$4.53M-4.07%
2025-03-11SaleDisc Medicine, Inc.
IRON
director
27,056
0.0784%
$54.01$1.46M-2.58%
2025-03-10SaleDisc Medicine, Inc.
IRON
director
202,146
0.5949%
$54.29$10.97M-0.5%
2025-01-14SalePassage Bio, Inc.
PASG
10 percent owner
79,024
0.1279%
$0.60$47,414-7.13%
2025-01-13SalePassage Bio, Inc.
PASG
10 percent owner
17,986
0.0293%
$0.64$11,511-12.92%
2025-01-10SalePassage Bio, Inc.
PASG
10 percent owner
126,209
0.2013%
$0.66$83,298-16.42%
2025-01-08SalePassage Bio, Inc.
PASG
10 percent owner
75,007
0.127%
$0.68$51,005-14.92%
2025-01-07SalePassage Bio, Inc.
PASG
10 percent owner
52,536
0.0851%
$0.71$37,301-19.81%
2025-01-06SalePassage Bio, Inc.
PASG
10 percent owner
19,481
0.0315%
$0.77$15,000-25.96%
2024-12-20SalePassage Bio, Inc.
PASG
10 percent owner
230,321
0.3317%
$0.60$138,193-12.67%
2024-12-11SalePassage Bio, Inc.
PASG
10 percent owner
80
0.0001%
$0.80$64-22.83%
2024-12-10SalePassage Bio, Inc.
PASG
10 percent owner
8,015
0.013%
$0.80$6,412-26.17%
2024-12-09SalePassage Bio, Inc.
PASG
10 percent owner
54,181
0.0924%
$0.84$45,512-26.49%
2024-12-06SalePassage Bio, Inc.
PASG
10 percent owner
20,903
0.0352%
$0.82$17,140-23.73%
2024-12-04SalePassage Bio, Inc.
PASG
10 percent owner
76,200
0.1269%
$0.79$60,198-20.38%
2024-09-19SalePassage Bio, Inc.
PASG
10 percent owner
39,300
0.0645%
$0.71$27,903-13.72%
2024-09-18SalePassage Bio, Inc.
PASG
10 percent owner
25,631
0.0432%
$0.73$18,711-13.77%
2024-09-17SalePassage Bio, Inc.
PASG
10 percent owner
111,400
0.181%
$0.73$81,322-16.77%
2024-09-16SalePassage Bio, Inc.
PASG
10 percent owner
63,100
0.1035%
$0.74$46,694-17.04%
2024-08-26SaleARS Pharmaceuticals, Inc.
SPRY
director
83,695
0.0772%
$13.00$1.09M+0.76%
Total: 311
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.